Point72 Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Sell |
45,100
-43,273
| -49% | -$202K | ﹤0.01% | 1184 |
|
|
2025
Q1 | $485K | Buy |
+88,373
| New | +$485K | ﹤0.01% | 989 |
|
|
2023
Q4 | – | Sell |
-655,000
| Closed | -$1.22M | – | 2173 |
|
|
2023
Q3 | $1.22M | Buy |
+655,000
| New | +$1.22M | ﹤0.01% | 883 |
|
|
2023
Q1 | – | Sell |
-60,000
| Closed | -$79.8K | – | 2032 |
|
|
2022
Q4 | $79.8K | Buy |
+60,000
| New | +$79.8K | ﹤0.01% | 932 |
|
|
2020
Q3 | – | Sell |
-232,410
| Closed | -$618K | – | 1062 |
|
|
2020
Q2 | $618K | Buy |
+232,410
| New | +$618K | ﹤0.01% | 664 |
|
|
2018
Q3 | – | Sell |
-5,000
| Closed | -$95K | – | 1071 |
|
|
2018
Q2 | $95K | Buy |
+5,000
| New | +$95K | ﹤0.01% | 770 |
|